These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16529058)

  • 1. [Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004].
    Swistak P; Dzielicki M; Janiec R; Błońska-Fajfrowska B
    Wiad Lek; 2005; 58(9-10):495-9. PubMed ID: 16529058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug expenditures of pensioners in 1997-2000].
    Swistak P; Błońska-Fajfrowska B
    Wiad Lek; 2003; 56(1-2):85-8. PubMed ID: 12901276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in prescribing behaviors after implementing drug reimbursement rate reduction policy in Taiwan: implications for the medicare system.
    Chu HL; Liu SZ; Romeis JC
    J Health Care Finance; 2008; 34(3):45-54. PubMed ID: 18468378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reimbursement of drug expenses--unseen problem, increasing threats].
    Lukawiecki K
    Kardiol Pol; 2006 Jul; 64(7):767-9; discussion 770. PubMed ID: 16886139
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative analysis of the impact of a positive list system on new chemical entity drugs and incrementally modified drugs in South Korea.
    Ha D; Choi Y; Kim DU; Chung KH; Lee EK
    Clin Ther; 2011 Jul; 33(7):926-32. PubMed ID: 21715008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
    Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
    Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.
    O'Reilly DJ; Goeree RA; Tarride JE; James C; Parfrey PS
    Can J Clin Pharmacol; 2009; 16(2):e346-59. PubMed ID: 19531813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stratification of drug expenditures incurred by Poles.
    Swistak P; Wikiński M; Swistak J; Błonska-Fajfrowska B
    Wiad Lek; 2007; 60(9-10):429-32. PubMed ID: 18350716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. By the Numbers. Prescription drugs and supplies.
    Mod Healthc; 2001 Dec; 31(52 Suppl):30. PubMed ID: 11808395
    [No Abstract]   [Full Text] [Related]  

  • 11. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug coverage insurance as a novel element of private health insurance in Poland.
    Czerw A; Religioni U
    Acta Pol Pharm; 2013; 70(4):763-7. PubMed ID: 23923401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [National Health Insurance expenditures in 1994 for thirty long-term illness].
    Fender P; Païta M; Salanave B; Ganay D; Allemand H
    Sante Publique; 2000 Mar; 12(1):5-19. PubMed ID: 10850139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Barmer reimbursement insurance pays pharmacists a fee for monitoring physicians. Pharmacists now control their prescriptions!].
    Schmidt K
    MMW Fortschr Med; 2004 May; 146(21):55-6. PubMed ID: 15373087
    [No Abstract]   [Full Text] [Related]  

  • 15. Doctor pharmaceutical utilization behaviour changed by the global budget programme strategies on hypertensive outpatient prescription.
    Wei CK; Wang SM; Yeh MK
    J Eval Clin Pract; 2012 Apr; 18(2):262-8. PubMed ID: 21040251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. By the numbers. The rising costs of prescription drugs.
    Thornton D
    Healthplan; 1999; 40(5):71-2. PubMed ID: 10622972
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis confirms pharmacy driving health care cost hikes.
    Capitation Manag Rep; 2001 Jan; 8(1):7-8, 1. PubMed ID: 11209218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of brand drug discount cards on private insurer, government and patient expenditures.
    Law MR; Chan FKI; Harrison M; Worthington HC
    CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.
    Alan S; Crossley TF; Grootendorst P; Veall MR
    J Health Econ; 2002 Sep; 21(5):805-26. PubMed ID: 12349883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public drug expenditure in the Republic of Ireland.
    Barry M; Usher C; Tilson L
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):239-45. PubMed ID: 20545588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.